DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "The Pharmaceutical Industry in South Africa 2016" report to their offering.
The pharmaceutical industry, a vital one which incorporates research and development, manufacture, import, distribution, wholesale and retail of pharmaceutical products, was valued at R39.3bn in 2015.
The report on the Pharmaceutical industry describes merger and acquisition activity, the latest regulatory developments and discusses factors influencing the success of the sector. The report profiles 90 companies ranging from South Africa's two largest pharmaceutical manufacturers, Aspen Pharmacare and Adcock Ingram to newcomers to the Top 20, Mylan and Valeant Pharmaceuticals which both have less than 2% share of the market.
Also profiled are African Medicines (Pty) Ltd t/a Pakmed Self Medication and GNLD International (Pty) Ltd, companies that use the services of contract manufacturers such as Wrapsa. Large national retailers with in-house pharmacies like Clicks and Pick n Pay, which have proved to be fierce competition to traditional independent and community pharmacies, are also profiled in this report.
Key Topics Covered:
1. Introduction
2. Description Of The Industry
3. Size Of The Industry
4. State Of The Industry
5. Influencing Factors
6. Competition
7. SWOT Analysis
8. Outlook
9. Industry Associations
10. References
For more information about this report visit http://www.researchandmarkets.com/research/fkjcsq/the
